Abstract
This study examines the impact of a mass casualty event (MCE) on a Gaza hospital during a military operation in June 2024, highlighting unique challenges encountered in conflict-zone medical care. The research analyses 47 casualties received by the Shuhada al-Aqsa Hospital in Deir-al-Balah, Gaza, over a concentrated period. Data collected include demographics, injury types, and pre-hospital and emergency department treatment delays. Findings reveal a predominance of blast injuries (76.6%), with compound injuries being present in 78.7% of casualties, resulting in a high injury burden (mean 1.68 injuries per casualty). The mean age of all casualties was 30.57 years. Mortality reached 14.89%, with females disproportionately affected, comprising 71.43% of fatalities. Transportation delays averaged 18.7 minutes, often without pre-arrival notification, underscoring logistical challenges in the Gaza conflict setting. In-hospital delays for treatment averaged 17.4 minutes. Gender disparities in trauma outcomes suggest biological and sociocultural factors influencing survival rates. The study emphasises the need for conflict-sensitive, gender-informed medical interventions, improved trauma care resources, and pre-hospital coordination protocols. This work aims to inform international medical volunteers on the realities of conflict-zone healthcare and support system-level improvements in MCE responses in resource-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Permission to undertake this study, and report these findings, was given by the administration and Medical Director of Shuhada al-Aqsa Hospital, Deir-al-Balah, Gaza. We have ensured that no patient is identifiable in this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Competing interest statement: Neither the authors nor their institutions received any payments or services in the past 36 months from a third party that influenced the submitted work. No funding was required, nor provided for this study.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
